Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells-Reference-Cited by-同舟云学术

Dipeptidyl peptidase-IV expression and activity in human glomerular endothelial cells

Published:2003-10 Issue:1 Volume:310 Page:28-31
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Pala Laura,Mannucci Edoardo,Pezzatini Anna,Ciani Silvia,Sardi Jacopo,Raimondi Laura,Ognibene Agostino,Cappadona Angela,Vannelli Barbara G,Rotella Carlo M

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference15 articles.

1. Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1-(7–36) amide, peptide histidine methionine, and is responsible for their degradation in human serum;Mentlein;Eur. J. Biochem.,1993

2. Inhibition of the activity of dipeptidyl peptidase IV as a treatment for type 2 diabetes;Holst;Diabetes,1998

3. Reduced postprandial concentration of intact biologically active glucagon-like peptide-1 in type 2 diabetic patients;Visboll;Diabetes,2001

4. Effect of nutrient ingestion on glucagon-like peptide-1 (7–36 amide) secretion in human type 1 and type 2 diabetes;Lugari;Horm. Metab. Res.,2000

5. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)—evidence for decreased glucagon-like peptide-1 secretion during oral glucose ingestion in NIDDM twins;Vaag;Eur. J. Endocrinol.,1996

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells;Viruses;2024-08-02

2. Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction;Cardiovascular Diabetology;2022-02-02

3. Evaluation of antioxidant, anti-inflammatory, and anti-hyperglycemic effects of Wattakaka volubilis Linn. f;Process Biochemistry;2022-01

4. Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review;Kidney Medicine;2021-11

5. Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study;Cardiovascular Diabetology;2021-08-13